Skip to main content
Log in

Soluble Interleukin-2 Receptor in Sjo¨gren’s Syndrome: Relation to Main Serum Immunological and Immunohistochemical Parameters

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Our aim was to study sIL-2R relationship with main serum immunological and LSG immunohistochemical parameters, including surface antigen expression of immune activation, in 27 patients with primary SS. Serum sIL-2R levels were significantly higher in SS (p<0.00005), as well as in SLE (p<0.05) and RA (p< 0.000001) patients than in controls. In SS patients with abnormal sIL-2R values (n= 7) we found higher levels of anti-SSB/La antibodies (p<0.05), IgM-RF (p<0.014) and CRP (p<0.003) with respect to those with normal sIL-2R values (n= 20). Moreover, sIL-2R levels correlated positively with those of anti-SSB/La antibodies (p<0.0037) and with CRP (p<0.008). The comparison of groups with (A) and without (B) abnormal sIL-2R levels reveals a statistically different percentage of patients with foci number >1 (86% vs 40%; p<0.047), and CD25 expression on lymphocytes (100% vs 40%; p<0.008). The frequency (p<0.025) of CD25 expression on lymphocytes was higher in group A than in group B. The frequency of CD25 expression on the infiltrates correlated not only with sIL-2R levels (p<0.047), but also with anti-SSB/La antibody values (p<0.044), with Tarpley histological classes (p<0.009) and with frequency of HLA-DR expression on lymphocytes (p<0.004) and on epithelial cells (p<0.002). The frequency of epithelial CD25 expression also correlated with that of epithelial HLA-DR (p<0.004). Our report suggests that sIL-2R is linked to glandular involvement in primary SS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 17 August 2000 / Accepted: 4 April 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spadaro, A., Riccieri, V., Benfari, G. et al. Soluble Interleukin-2 Receptor in Sjo¨gren’s Syndrome: Relation to Main Serum Immunological and Immunohistochemical Parameters. Clin Rheumatol 20, 319–323 (2001). https://doi.org/10.1007/s100670170020

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100670170020

Navigation